Skip to main content
CHCO
NASDAQ Finance

City Holding Co. Details Executive Compensation, Board Nominees, and Shareholder Proposals for Annual Meeting

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Neutral
Importance info
7
Price
$119.99
Mkt Cap
$1.722B
52W Low
$102.22
52W High
$133.59
Market data snapshot near publication time

summarizeSummary

City Holding Co. filed its definitive proxy statement for the upcoming April 29, 2026 Annual Meeting, detailing executive compensation for 2025, including significant performance-based payouts and substantial change-of-control severance packages, alongside board director nominees.


check_boxKey Events

  • Annual Shareholder Meeting Scheduled

    The Annual Meeting of Shareholders is set for April 29, 2026, with a record date of March 16, 2026. Shareholders will vote on director elections, auditor ratification, and executive compensation.

  • New Director Nominee Introduced

    B. Scott Raynes, President and CEO of Marshall Health Network, has been nominated as a Class II director to serve a two-year term, joining four Class III director nominees for re-election.

  • Detailed 2025 Executive Compensation Disclosed

    The company reported strong 2025 financial performance, including $130.5 million in net income and a 21.2% ROATCE, leading to executive cash incentives at 190% of targeted payout levels. The CEO's total compensation was $1,922,194, resulting in a 42x pay ratio to the median employee.

  • Substantial Change-of-Control Severance Packages

    Named executive officers have significant post-employment benefits, with CEO Charles R. Hageboeck having a fully vested termination benefit of $1,534,017 and a potential total payout of $5,769,394 in a change-of-control scenario.


auto_awesomeAnalysis

This definitive proxy statement provides investors with crucial insights into City Holding Co.'s corporate governance and executive compensation practices ahead of its Annual Meeting. The detailed 2025 compensation report highlights strong performance-based incentives, reflecting the company's record net income and superior ROAA/ROATCE compared to peers. However, the disclosure of substantial change-of-control severance benefits for named executive officers, particularly the CEO's potential $5.77 million payout, represents a material financial consideration for shareholders in potential M&A scenarios. The election of directors, including a new nominee, and the advisory vote on executive compensation are standard annual agenda items, but the comprehensive financial and governance data presented is vital for assessing management alignment and potential liabilities.

At the time of this filing, CHCO was trading at $119.99 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $102.22 to $133.59. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CHCO - Latest Insights

CHCO
Apr 23, 2026, 11:12 AM EDT
Filing Type: 8-K
Importance Score:
8
CHCO
Mar 27, 2026, 2:38 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CHCO
Mar 26, 2026, 11:02 AM EDT
Filing Type: 8-K
Importance Score:
8
CHCO
Mar 25, 2026, 5:59 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CHCO
Feb 25, 2026, 3:24 PM EST
Filing Type: 10-K
Importance Score:
9
CHCO
Feb 03, 2026, 5:52 PM EST
Filing Type: 8-K
Importance Score:
8
CHCO
Jan 21, 2026, 10:29 AM EST
Filing Type: 8-K
Importance Score:
8